Intralesional Treatment of Keloids

Sohag University

Status and phase: Enrolling; Phase 3

Conditions: Scar, Hypertrophic

Treatments: Drug: Injection

Study type: Interventional

Funder types: Other

Identifiers

NCT06729840

Soh-Med--24-11-05MS

Details and patient eligibility

About

Intralesional injection in treatment of keloid

Full description

Our study will include 45 patient diveded into three groups , follow up will done before each session , 3month after the last session using photographing assessment , scoring , dermoscope

Enrollment: 45 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Both sex aged 18-60 having keloid

Exclusion criteria

• pregnancy , lactation Skin disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

45 participants in 3 patient groups

Group 1

Active Comparator group

Description:

Will include 15 patients will injected with vitamin D

Treatment:

Drug: Injection

Group 2

Active Comparator group

Description:

Will include 15 patients will injected with botulinum toxin type A

Treatment:

Drug: Injection

Group 3

Active Comparator group

Description:

Will include 15 patients will injected with triamcinolone acetonide

Treatment:

Drug: Injection